Pharmaceutical News

RSS

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Shionogi Limited, the London-based European subsidiary of Shionogi & Co., Ltd announced today that on 26th March 2013 the European Medicines Agency accepted its Marketing Authorisation Application submission for ospemifene for the treatment of vulvar and vaginal atrophy in post-menopausal women.

27 Mar 2013

New data reveals impact of opioid-related adverse events on length, cost of hospitalization after surgery

Pacira Pharmaceuticals, Inc. today announced data from a large-scale analysis of a national database of patients from 380 hospitals in the United States who underwent 319,898 inpatient surgeries and received opioids for postsurgical pain management.

27 Mar 2013

Oncodesign signs agreement with Sanofi to identify kinase inhibitors involved in tissue protection and repair

Oncodesign, a company specializing in drug discovery and providing pharmacological evaluation services in the field of oncology, today announces that it has signed a second research collaboration agreement with Sanofi.

27 Mar 2013

Biological scientists lead major research project that aims to make drugs more effective

University of Southampton biological scientists are leading a major research project aimed at making drugs more effective.

27 Mar 2013

Review article shows sublingual immunotherapy may be useful for allergic rhinitis, asthma

In an examination of a type of treatment for allergic rhinitis and asthma that is used in Europe but not approved by the U.S. Food and Drug Administration, researchers found moderate strength in the evidence from previous studies to support the use of sublingual immunotherapy for the treatment of these conditions, according to an article in the March 27 issue of JAMA.

27 Mar 2013

Oral drops are good for treating symptoms of allergies, allergic asthma in some people: Review

A scientific review of 63 published studies affirms that putting small amounts of purified grasses, ragweed, dust mites, pollen and mold, in liquid drops under the tongue is a safe and effective alternative to weekly injections of those allergens or the use of other medications, in treating symptoms of allergies and allergic asthma in some people.

27 Mar 2013

Certified stroke centers more likely to administer clot-busting treatment for strokes

Certified Primary Stroke Centers are three times more likely to administer clot-busting treatment for strokes than non-certified centers, reports a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania.

27 Mar 2013

Indonesia to issue compulsory licenses for HIV, hepatitis B drugs still under patent

"The Indonesian government hopes to implement one of the largest ever examples of 'compulsory licensing,' which will enable the generic manufacture of drugs still under patent," IRIN reports.

27 Mar 2013

Researchers find HPV vaccination disparities among low-income females

Researchers at Moffitt Cancer Center and colleagues at the University of Florida studied health care providers to determine the factors associated with disparities in Human Papillomavirus (HPV) vaccination among girls, ages 9 to 17, from low-income families.

27 Mar 2013

Viewpoints: Rising cost of Tricare; GOP needs to better explain Medicare eligibility age issue; Don't forget adult immunizations

The U.S. government's fiscal predicament has many causes. But if you had to reduce them to one sentence, it might go like this: "Congress responds to the short-term demands of particular groups, not the long-term needs of the nation as a whole."

27 Mar 2013

Questions from High Court suggest concerns about 'pay-for-delay' deals

The Supreme Court heard arguments yesterday in a case which pits brand name and generic drug manufacturers against the Federal Trade Commission.

27 Mar 2013

Lundbeck, Otsuka reach agreement to develop and commercialize Lu AE58054

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. today announced a license and development agreement for Lu AE58054, a selective 5HT6 receptor antagonist currently in development for the treatment of Alzheimer's disease.

26 Mar 2013

Clinigen announces acquisition of Cardioxane from Novartis

Clinigen Group plc today announced the acquisition of Cardioxane (dexrazoxane) from Novartis for US$33 million in cash, payable in two tranches.

From Clinigen Group 26 Mar 2013

New vaccine proves highly effective against H5N1 virus

Until now most experimental vaccines against the highly lethal H5N1 avian influenza virus have lacked effectiveness. But a new vaccine has proven highly effective against the virus when tested in both mice and ferrets. It is also effective against the H9 subtype of avian influenza.

26 Mar 2013

Experts to meet in Cape Town to discuss development of vaccines for deadly airborne disease

At a time of growing global concern about the rising level of drug-resistant strains of tuberculosis in South Africa and worldwide, the world's top TB vaccine experts are meeting this week, the first time this scientific forum has been held in Africa, where they will present new research aimed at advancing development of vaccines against the deadly airborne disease.

26 Mar 2013

Supreme Court to hear case about 'pay to delay' deals between generic and branded drug makers

Generic and the brand-name drug companies -- usually fierce competitors -- will be on the same side as they argue their case against the federal government.

26 Mar 2013

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

VIVUS, Inc. announced today that a new study demonstrates that effective medical treatment providing 10% to 15% weight loss could lead to significant improvements in Medicare spending by reversing or reducing significant health consequences such as type 2 diabetes, hypertension and dyslipidemia in obese or overweight patients.

25 Mar 2013

arGEN-X advances ARGX-112 into formal preclinical development

arGEN-X, a clinical stage biopharmaceutical company specialized in the discovery and development of highly differentiated human monoclonal antibody therapeutics, announces that it has progressed ARGX-112, its fourth therapeutic candidate, into formal preclinical development.

25 Mar 2013

Scientists develop new chemo drug that fights cancer without impacting fertility

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.

25 Mar 2013

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

Pfizer Inc. announced today that the Japanese Ministry of Health, Labor and Welfare has approved XELJANZ (tofacitinib citrate) for the treatment of adults with rheumatoid arthritis who have had an inadequate response to existing therapies.

25 Mar 2013

Pharmaceutical News

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

New data reveals impact of opioid-related adverse events on length, cost of hospitalization after surgery

Oncodesign signs agreement with Sanofi to identify kinase inhibitors involved in tissue protection and repair

Biological scientists lead major research project that aims to make drugs more effective

Review article shows sublingual immunotherapy may be useful for allergic rhinitis, asthma

Oral drops are good for treating symptoms of allergies, allergic asthma in some people: Review

Certified stroke centers more likely to administer clot-busting treatment for strokes

Indonesia to issue compulsory licenses for HIV, hepatitis B drugs still under patent

Researchers find HPV vaccination disparities among low-income females

Viewpoints: Rising cost of Tricare; GOP needs to better explain Medicare eligibility age issue; Don't forget adult immunizations

Questions from High Court suggest concerns about 'pay-for-delay' deals

Lundbeck, Otsuka reach agreement to develop and commercialize Lu AE58054

Clinigen announces acquisition of Cardioxane from Novartis

New vaccine proves highly effective against H5N1 virus

Experts to meet in Cape Town to discuss development of vaccines for deadly airborne disease

Supreme Court to hear case about 'pay to delay' deals between generic and branded drug makers

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

arGEN-X advances ARGX-112 into formal preclinical development

Scientists develop new chemo drug that fights cancer without impacting fertility

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News